You can:
Name | Adenosine receptor A1 |
---|---|
Species | Rattus norvegicus (Rat) |
Gene | Adora1 |
Synonym | A1 receptor A1-AR A1R adenosine receptor A1 RDC7 |
Disease | N/A for non-human GPCRs |
Length | 326 |
Amino acid sequence | MPPYISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKTVVTQRRAAVAIAGCWILSLVVGLTPMFGWNNLSVVEQDWRANGSVGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPTCQKPSILIYIAIFLTHGNSAMNPIVYAFRIHKFRVTFLKIWNDHFRCQPKPPIDEDLPEEKAED |
UniProt | P25099 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL318 |
IUPHAR | 18 |
DrugBank | N/A |
Name | CHEMBL54505 |
---|---|
Molecular formula | C24H30N6O3 |
IUPAC name | N-[(2R,3R,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-4-hydroxy-2-methyloxolan-3-yl]-3,4-dimethylbenzamide |
Molecular weight | 450.543 |
Hydrogen bond acceptor | 7 |
Hydrogen bond donor | 3 |
XlogP | 2.9 |
Synonyms | BDBM50112199 N-[5-(6-Cyclopentylamino-purin-9-yl)-4-hydroxy-2-methyl-tetrahydro-furan-3-yl]-3,4-dimethyl-benzamide |
Inchi Key | ANEWOVOUCFPRTN-XGFUBRKBSA-N |
Inchi ID | InChI=1S/C24H30N6O3/c1-13-8-9-16(10-14(13)2)23(32)29-18-15(3)33-24(20(18)31)30-12-27-19-21(25-11-26-22(19)30)28-17-6-4-5-7-17/h8-12,15,17-18,20,24,31H,4-7H2,1-3H3,(H,29,32)(H,25,26,28)/t15-,18+,20-,24-/m1/s1 |
PubChem CID | 11080871 |
ChEMBL | CHEMBL54505 |
IUPHAR | N/A |
BindingDB | 50112199 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 236.0 nM | PMID11960496 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417